Industry
CVS Aetna Bundles Cancer Prior Authorizations Into Single Upfront Request
CVS Aetna announced it will consolidate prior authorization requirements for cancer care into one upfront approval covering all treatment types, replacing the current piecemeal approach that requires separate authorizations for different services. The change aims to reduce administrative burden on oncology providers who currently submit multiple prior authorization requests throughout a patient's cancer treatment episode. The new bundled authorization process will apply across CVS Aetna's commercial and Medicare Advantage plans. This affects how oncologists interact with CVS Aetna's utilization management systems and may influence treatment access and care coordination for cancer patients.
Why it mattersThis operational change by a major commercial and Medicare Advantage carrier may set precedent for how Medicaid managed care plans structure prior authorization for complex conditions requiring multi-modal treatment.